Publications by authors named "P Senesse"

Claim this Profile
R
Reply to: Oxaliplatin Dosing and Toxicity: A Cautionary Perspective on Efficacy.
Eric Assenat, Pierre Senesse

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Impact of Lean Body Mass-Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX Trial.
Eric Assenat, Meher Ben Abdelghani, Sophie Gourgou, Hervé Perrier, Faiza Khemissa Akouz, Pierre Senesse

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for reduced food intake in 2 minutes: validation of the ingesta verbal analogue scale in medical geriatric oncology.
Pierre Senesse, Julie Deffrennes, Nicolas Flori, Chloé Janiszewski, Laure Francioni

Eur J Clin Nutr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of physical rehabilitation in patients receiving curative treatment for head and neck cancer: The NUTRIMOUV randomized phase II trial.
Marie Vinches, Chloé Janiszewski, Simon Thezenas, Delphine Delample, Pierre Boisselier, Pierre Senesse

Support Care Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Lean Body Mass-Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX Trial.
Eric Assenat, Meher Ben Abdelghani, Sophie Gourgou, Hervé Perrier, Faiza Khemissa Akouz, Pierre Senesse

J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis